{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:08:25Z","timestamp":1760299705927,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T00:00:00Z","timestamp":1506988800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00277-017-3145-0","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T04:52:55Z","timestamp":1507092775000},"page":"355-357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PET-positive bone lesion due to Langerhans cell histiocytosis after BEACOPP therapy for Hodgkin lymphoma: how anamnesis, histopathological accuracy, and molecular analysis could resolve a clinical dilemma"],"prefix":"10.1007","volume":"97","author":[{"given":"Simon","family":"Haefliger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Bihl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatime","family":"Krasniqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-3819","authenticated-orcid":false,"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,3]]},"reference":[{"key":"3145_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bjh.13247","volume":"169","author":"ML Berres","year":"2015","unstructured":"Berres ML, Merad M, Allen CE (2015) Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? Br J Haematol 169:3\u201313. \nhttps:\/\/doi.org\/10.1111\/bjh.13247","journal-title":"Br J Haematol"},{"key":"3145_CR2","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","volume":"116","author":"G Badalian-Very","year":"2010","unstructured":"Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Fleming MD, Rollins BJ (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116:1919\u20131923. \nhttps:\/\/doi.org\/10.1182\/blood-2010-04-279083","journal-title":"Blood"},{"key":"3145_CR3","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","volume":"124","author":"NA Brown","year":"2014","unstructured":"Brown NA, Furtado LV, Betz BL, Kiel MJ, Weigelin HC, Lim MS, Elenitoba-Johnson KS (2014) High prevalence of somatic MAP2K1 mutations in BRAF V600E\u2013negative Langerhans cell histiocytosis. Blood 124:1655\u20131658. \nhttps:\/\/doi.org\/10.1182\/blood-2014-05-577361","journal-title":"Blood"},{"key":"3145_CR4","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/modpathol.2016.235","volume":"30","author":"S Pina-Oviedo","year":"2017","unstructured":"Pina-Oviedo S, Medeiros LJ, Li S, Khoury JD, Patel KP, Alayed K, Cason RC, Bowman CJ, Yin CC (2017) Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations. Mod Pathol 30:734\u2013744. \nhttps:\/\/doi.org\/10.1038\/modpathol.2016.235","journal-title":"Mod Pathol"},{"key":"3145_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.humpath.2005.08.024","volume":"37","author":"LJ Christie","year":"2006","unstructured":"Christie LJ, Evans AT, Bray SE, Smith ME, Kernohan NM, Levison DA, Goodlad JR (2006) Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon? Hum Pathol 37:32\u201339. \nhttps:\/\/doi.org\/10.1016\/j.humpath.2005.08.024","journal-title":"Hum Pathol"},{"key":"3145_CR6","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/bjh.14292","volume":"175","author":"C Mesguich","year":"2016","unstructured":"Mesguich C, Cazeau AL, Bouabdallah K, Soubeyran P, Guyot M, Milpied N, Bordenave L, Hindi\u00e9 E (2016) Hodgkin lymphoma: a negative interim-PET cannot circumvent the need for end-of-treatment-PET evaluation. Br J Haematol 175:652\u2013660. \nhttps:\/\/doi.org\/10.1111\/bjh.14292","journal-title":"Br J Haematol"},{"key":"3145_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3816\/CLM.2002.n.019","volume":"3","author":"R Naumann","year":"2002","unstructured":"Naumann R, Beuthien-Baumann B, Fischer R, Kittner T, Bredow J, Kropp J, Ockert D, Ehninger G (2002) Simultaneous occurrence of Hodgkin\u2019s lymphoma and eosinophilic granuloma: a potential pitfall in positron emission tomography imaging. Clin Lymphoma Myeloma Leuk 3:121\u2013124. \nhttps:\/\/doi.org\/10.3816\/CLM.2002.n.019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3145_CR8","first-page":"65","volume":"86","author":"MS Shin","year":"1994","unstructured":"Shin MS, Buchalter SE, Ho KJ (1994) Langerhans cell histiocytosis associated with Hodgkin\u2019s disease: a case report. J Natl Med Assoc 86:65\u201369","journal-title":"J Natl Med Assoc"},{"key":"3145_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0889-8588(05)70516-5","volume":"12","author":"RM Egeler","year":"1998","unstructured":"Egeler RM, Neglia JP, Arico M, Favara BE, Heitger A, Nesbit ME, Nicholson HS (1998) The relation of Langerhans cell histiocytosis to acute leukaemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society Hematol Oncol Clin North Am 12:369\u2013378. \nhttps:\/\/doi.org\/10.1016\/S0889-8588(05)70516-5","journal-title":"The LCH-Malignancy Study Group of the Histiocyte Society Hematol Oncol Clin North Am"},{"key":"3145_CR10","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/ijc.28189","volume":"133","author":"A Natoli","year":"2013","unstructured":"Natoli A, L\u00fcpertz R, Merz C, M\u00fcller WW, K\u00f6hler R, Krammer PH, Li-Weber M (2013) Targeting the IL-4\/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs. Int J Cancer 133:1945\u20131954. \nhttps:\/\/doi.org\/10.1002\/ijc.28189","journal-title":"Int J Cancer"},{"key":"3145_CR11","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1182\/blood-2016-11-749374","volume":"129","author":"S Loghavi","year":"2017","unstructured":"Loghavi S, Khoury JD (2017) Langerhans cell histiocytosis in a patient with hairy cell leukemia: a tale of divergence. Blood 129:1563. \nhttps:\/\/doi.org\/10.1182\/blood-2016-11-749374","journal-title":"Blood"},{"key":"3145_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2017.1361029","volume":"9","author":"GL Ryland","year":"2017","unstructured":"Ryland GL, Jones K, McBean M, Khot A, Seymour JF, Blombery P (2017) Comprehensive genomic characterization dissects the complex biology of a case of synchronous Burkitt lymphoma and myeloid malignancy with shared hematopoietic ancestry. Leuk Lymphoma 9:1\u20134. \nhttps:\/\/doi.org\/10.1080\/10428194.2017.1361029","journal-title":"Leuk Lymphoma"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-3145-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3145-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3145-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T23:33:50Z","timestamp":1515022430000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-3145-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,3]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["3145"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-3145-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2017,10,3]]}}}